Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.

Recently, we have found that the skin secretions of the Amazonian tree frog Phyllomedusa bicolor contains molecules with antitumor and angiostatic activities and identified one of them as the antimicrobial peptide dermaseptin (Drs) B2. In the present study we further explored the in vitro and in viv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanneke van Zoggel, Gilles Carpentier, Célia Dos Santos, Yamina Hamma-Kourbali, José Courty, Mohamed Amiche, Jean Delbé
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9911662aeebc4a99ba9aa6590f8c9104
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9911662aeebc4a99ba9aa6590f8c9104
record_format dspace
spelling oai:doaj.org-article:9911662aeebc4a99ba9aa6590f8c91042021-11-18T07:04:49ZAntitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.1932-620310.1371/journal.pone.0044351https://doaj.org/article/9911662aeebc4a99ba9aa6590f8c91042012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23028527/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Recently, we have found that the skin secretions of the Amazonian tree frog Phyllomedusa bicolor contains molecules with antitumor and angiostatic activities and identified one of them as the antimicrobial peptide dermaseptin (Drs) B2. In the present study we further explored the in vitro and in vivo antitumor activity of this molecule and investigated its mechanism of action. We showed that Drs B2 inhibits the proliferation and colony formation of various human tumor cell types, and the proliferation and capillary formation of endothelial cells in vitro. Furthermore, Drs B2 inhibited tumor growth of the human prostate adenocarcinoma cell line PC3 in a xenograft model in vivo. Research on the mechanism of action of Drs B2 on tumor PC3 cells demonstrated a rapid increasing amount of cytosolic lactate dehydrogenase, no activation of caspase-3, and no changes in mitochondrial membrane potential. Confocal microscopy analysis revealed that Drs B2 can interact with the tumor cell surface, aggregate and penetrate the cells. These data together indicate that Drs B2 does not act by apoptosis but possibly by necrosis. In conclusion, Drs B2 could be considered as an interesting and promising pharmacological and therapeutic leader molecule for the treatment of cancer.Hanneke van ZoggelGilles CarpentierCélia Dos SantosYamina Hamma-KourbaliJosé CourtyMohamed AmicheJean DelbéPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e44351 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hanneke van Zoggel
Gilles Carpentier
Célia Dos Santos
Yamina Hamma-Kourbali
José Courty
Mohamed Amiche
Jean Delbé
Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
description Recently, we have found that the skin secretions of the Amazonian tree frog Phyllomedusa bicolor contains molecules with antitumor and angiostatic activities and identified one of them as the antimicrobial peptide dermaseptin (Drs) B2. In the present study we further explored the in vitro and in vivo antitumor activity of this molecule and investigated its mechanism of action. We showed that Drs B2 inhibits the proliferation and colony formation of various human tumor cell types, and the proliferation and capillary formation of endothelial cells in vitro. Furthermore, Drs B2 inhibited tumor growth of the human prostate adenocarcinoma cell line PC3 in a xenograft model in vivo. Research on the mechanism of action of Drs B2 on tumor PC3 cells demonstrated a rapid increasing amount of cytosolic lactate dehydrogenase, no activation of caspase-3, and no changes in mitochondrial membrane potential. Confocal microscopy analysis revealed that Drs B2 can interact with the tumor cell surface, aggregate and penetrate the cells. These data together indicate that Drs B2 does not act by apoptosis but possibly by necrosis. In conclusion, Drs B2 could be considered as an interesting and promising pharmacological and therapeutic leader molecule for the treatment of cancer.
format article
author Hanneke van Zoggel
Gilles Carpentier
Célia Dos Santos
Yamina Hamma-Kourbali
José Courty
Mohamed Amiche
Jean Delbé
author_facet Hanneke van Zoggel
Gilles Carpentier
Célia Dos Santos
Yamina Hamma-Kourbali
José Courty
Mohamed Amiche
Jean Delbé
author_sort Hanneke van Zoggel
title Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
title_short Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
title_full Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
title_fullStr Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
title_full_unstemmed Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.
title_sort antitumor and angiostatic activities of the antimicrobial peptide dermaseptin b2.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/9911662aeebc4a99ba9aa6590f8c9104
work_keys_str_mv AT hannekevanzoggel antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT gillescarpentier antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT celiadossantos antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT yaminahammakourbali antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT josecourty antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT mohamedamiche antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
AT jeandelbe antitumorandangiostaticactivitiesoftheantimicrobialpeptidedermaseptinb2
_version_ 1718423993765068800